BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hausser J, Alon U. Tumour heterogeneity and the evolutionary trade-offs of cancer. Nat Rev Cancer 2020;20:247-57. [PMID: 32094544 DOI: 10.1038/s41568-020-0241-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 19.5] [Reference Citation Analysis]
Number Citing Articles
1 Fiandaca G, Bernardi S, Scianna M, Delitala ME. A phenotype-structured model to reproduce the avascular growth of a tumor and its interaction with the surrounding environment. J Theor Biol 2021;:110980. [PMID: 34915043 DOI: 10.1016/j.jtbi.2021.110980] [Reference Citation Analysis]
2 Mejia I, Bodapati S, Chen KT, Díaz B. Pancreatic Adenocarcinoma Invasiveness and the Tumor Microenvironment: From Biology to Clinical Trials. Biomedicines 2020;8:E401. [PMID: 33050151 DOI: 10.3390/biomedicines8100401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nath A, Cosgrove PA, Mirsafian H, Christie EL, Pflieger L, Copeland B, Majumdar S, Cristea MC, Han ES, Lee SJ, Wang EW, Fereday S, Traficante N, Salgia R, Werner T, Cohen AL, Moos P, Chang JT, Bowtell DDL, Bild AH. Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer. Nat Commun 2021;12:3039. [PMID: 34031395 DOI: 10.1038/s41467-021-23171-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Parodi A, Kostyushev D, Brezgin S, Kostyusheva A, Borodina T, Akasov R, Frolova A, Chulanov V, Zamyatnin AA. Biomimetic approaches for targeting tumor inflammation. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.04.007] [Reference Citation Analysis]
5 Olivares-Urbano MA, Griñán-Lisón C, Marchal JA, Núñez MI. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer. Cells 2020;9:E1651. [PMID: 32660072 DOI: 10.3390/cells9071651] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
6 Jiménez-Sánchez J, Bosque JJ, Jiménez Londoño GA, Molina-García D, Martínez Á, Pérez-Beteta J, Ortega-Sabater C, Honguero Martínez AF, García Vicente AM, Calvo GF, Pérez-García VM. Evolutionary dynamics at the tumor edge reveal metabolic imaging biomarkers. Proc Natl Acad Sci U S A 2021;118:e2018110118. [PMID: 33536339 DOI: 10.1073/pnas.2018110118] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Castillo SP, Keymer JE, Marquet PA. Do microenvironmental changes disrupt multicellular organisation with ageing, enacting and favouring the cancer cell phenotype? Bioessays 2021;43:e2000126. [PMID: 33184914 DOI: 10.1002/bies.202000126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Afrasiabi K, Linskey ME, Zhou YH. Exploiting Cancer's Tactics to Make Cancer a Manageable Chronic Disease. Cancers (Basel) 2020;12:E1649. [PMID: 32580319 DOI: 10.3390/cancers12061649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yang L, Yin X, An B, Li F. Precise Capture and Direct Quantification of Tumor Exosomes via a Highly Efficient Dual-Aptamer Recognition-Assisted Ratiometric Immobilization-Free Electrochemical Strategy. Anal Chem 2021;93:1709-16. [PMID: 33369394 DOI: 10.1021/acs.analchem.0c04308] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
10 Ieni A, Vita R, Pizzimenti C, Benvenga S, Tuccari G. Intratumoral Heterogeneity in Differentiated Thyroid Tumors: An Intriguing Reappraisal in the Era of Personalized Medicine. J Pers Med 2021;11:333. [PMID: 33922518 DOI: 10.3390/jpm11050333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Duchmann M, Laplane L, Itzykson R. Clonal Architecture and Evolutionary Dynamics in Acute Myeloid Leukemias. Cancers (Basel) 2021;13:4887. [PMID: 34638371 DOI: 10.3390/cancers13194887] [Reference Citation Analysis]
12 Adler M, Tendler A, Hausser J, Korem Y, Szekely P, Bossel N, Hart Y, Karin O, Mayo A, Alon U. Controls for phylogeny and robust analysis in Pareto Task Inference. Mol Biol Evol 2021:msab297. [PMID: 34633456 DOI: 10.1093/molbev/msab297] [Reference Citation Analysis]
13 Liu Y, White KA, Barber DL. Intracellular pH Regulates Cancer and Stem Cell Behaviors: A Protein Dynamics Perspective. Front Oncol 2020;10:1401. [PMID: 32983969 DOI: 10.3389/fonc.2020.01401] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Paran Y, Liron Y, Batsir S, Mabjeesh N, Geiger B, Kam Z. Multi-parametric characterization of drug effects on cells. F1000Res 2020;9:ISF-1199. [PMID: 33363713 DOI: 10.12688/f1000research.26254.2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Mao Y, Wang X, Huang P, Tian R. Spatial proteomics for understanding the tissue microenvironment. Analyst 2021;146:3777-98. [PMID: 34042124 DOI: 10.1039/d1an00472g] [Reference Citation Analysis]
16 Ziemys A, Simic V, Milosevic M, Kojic M, Liu YT, Yokoi K. Attenuated Microcirculation in Small Metastatic Tumors in Murine Liver. Pharmaceutics 2021;13:703. [PMID: 34065867 DOI: 10.3390/pharmaceutics13050703] [Reference Citation Analysis]
17 Silveira CHD, Vieceli V, Clerici DJ, Santos RCV, Iglesias BA. Investigation of isomeric tetra-cationic porphyrin activity with peripheral [Pd(bpy)Cl]+ units by antimicrobial photodynamic therapy. Photodiagnosis and Photodynamic Therapy 2020;31:101920. [DOI: 10.1016/j.pdpdt.2020.101920] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
18 Plutynski A. How is cancer complex? Euro Jnl Phil Sci 2021;11. [DOI: 10.1007/s13194-021-00371-8] [Reference Citation Analysis]
19 Li S, Mao Q, Zhang Z, Wang Y, Chen D, Chen Z, Lu J, Alatas B. Identification of a Five-Gene Panel to Assess Prognosis for Gastric Cancer. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/5593619] [Reference Citation Analysis]
20 Telford BJ, Yahyanejad S, de Gunst T, den Boer HC, Vos RM, Stegink M, van den Bosch MTJ, Alemdehy MF, van Pinxteren LAH, Schaapveld RQJ, Janicot M. Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology. Oncotarget 2021;12:422-39. [PMID: 33747358 DOI: 10.18632/oncotarget.27894] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Capp JP, DeGregori J, Nedelcu AM, Dujon AM, Boutry J, Pujol P, Alix-Panabières C, Hamede R, Roche B, Ujvari B, Marusyk A, Gatenby R, Thomas F. Group phenotypic composition in cancer. Elife 2021;10:e63518. [PMID: 33784238 DOI: 10.7554/eLife.63518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Yang H, Xu D, Yang Z, Yao F, Zhao H, Schmid RA, Peng RW. Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma. Cancers (Basel) 2020;12:E2310. [PMID: 32824422 DOI: 10.3390/cancers12082310] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
23 Bochem J, Zelba H, Spreuer J, Amaral T, Gaissler A, Pop OT, Thiel K, Yurttas C, Soffel D, Forchhammer S, Sinnberg T, Niessner H, Meier F, Terheyden P, Königsrainer A, Garbe C, Flatz L, Pawelec G, Eigentler TK, Löffler MW, Weide B, Wistuba-hamprecht K. Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy. J Immunother Cancer 2021;9:e003439. [DOI: 10.1136/jitc-2021-003439] [Reference Citation Analysis]
24 Wang H, Pan J, Barsky L, Jacob JC, Zheng Y, Gao C, Wang S, Zhu W, Sun H, Lu L, Jia H, Zhao Y, Bruns C, Vago R, Dong Q, Qin L. Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways. Mol Biomed 2021;2:3. [PMID: 35006432 DOI: 10.1186/s43556-020-00022-z] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
25 Farhana A, Koh AE, Ling Mok P, Alsrhani A, Khan YS, Subbiah SK. Camptothecin Encapsulated in β-Cyclodextrin-EDTA-Fe3O4 Nanoparticles Induce Metabolic Reprogramming Repair in HT29 Cancer Cells through Epigenetic Modulation: A Bioinformatics Approach. Nanomaterials (Basel) 2021;11:3163. [PMID: 34947512 DOI: 10.3390/nano11123163] [Reference Citation Analysis]
26 Wang Z, Cui W. CRISPR‐Cas system for biomedical diagnostic platforms. View 2020;1:20200008. [DOI: 10.1002/viw.20200008] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Jornada DC, Garcia RQ, da Silveira CH, Misoguti L, Mendonça CR, Santos RCV, De Boni L, Iglesias BA. Investigation of the triplet excited state and application of cationic meso-tetra(cisplatin)porphyrins in antimicrobial photodynamic therapy. Photodiagnosis Photodyn Ther 2021;35:102459. [PMID: 34320427 DOI: 10.1016/j.pdpdt.2021.102459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Yang H, Xu D, Schmid RA, Peng RW. Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma. Ther Adv Med Oncol 2020;12:1758835920971421. [PMID: 33240401 DOI: 10.1177/1758835920971421] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
29 Yang L, Kim TH, Cho HY, Luo J, Lee JM, Chueng SD, Hou Y, Yin PT, Han J, Kim JH, Chung BG, Choi JW, Lee KB. Hybrid Graphene-Gold Nanoparticle-based Nucleic Acid Conjugates for Cancer-Specific Multimodal Imaging and Combined Therapeutics. Adv Funct Mater 2021;31:2006918. [PMID: 33776614 DOI: 10.1002/adfm.202006918] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
30 Yao W, Liao Y, Li X, Zhang F, Zhang H, Hu B, Wang X, Li L, Xiao M, M.a B. Noninvasive Method for Predicting the Expression of Ki67 and Prognosis in Non-Small-Cell Lung Cancer Patients: Radiomics. Journal of Healthcare Engineering 2022;2022:1-9. [DOI: 10.1155/2022/7761589] [Reference Citation Analysis]
31 Cook DP, Wrana JL. A specialist-generalist framework for epithelial-mesenchymal plasticity in cancer. Trends in Cancer 2022. [DOI: 10.1016/j.trecan.2022.01.014] [Reference Citation Analysis]
32 Petroni G, Buqué A, Zitvogel L, Kroemer G, Galluzzi L. Immunomodulation by targeted anticancer agents. Cancer Cell 2021;39:310-45. [PMID: 33338426 DOI: 10.1016/j.ccell.2020.11.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
33 Chen B, Yang L, Zhang R, Luo W, Li W. Radiomics: an overview in lung cancer management-a narrative review. Ann Transl Med 2020;8:1191. [PMID: 33241040 DOI: 10.21037/atm-20-4589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Buqué A, Galluzzi L. Preface: Chemical carcinogenesis in mice as a model of human cancer: Pros and cons. Methods Cell Biol 2021;163:xvii-xxv. [PMID: 33785172 DOI: 10.1016/S0091-679X(21)00040-6] [Reference Citation Analysis]
35 Wheat JC, Steidl U. Gene Expression at a Single Molecule Level: Implications for MDS and AML. Blood 2021:blood. [PMID: 34157070 DOI: 10.1182/blood.2019004261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Shlyakhtina Y, Moran KL, Portal MM. Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution. Cancers (Basel) 2021;13:1380. [PMID: 33803675 DOI: 10.3390/cancers13061380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
37 Mikami T, Iwasaki W, Blomberg S. The flipping t ‐ratio test: Phylogenetically informed assessment of the Pareto theory for phenotypic evolution. Methods Ecol Evol 2021;12:696-706. [DOI: 10.1111/2041-210x.13553] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
38 Kunimasa K, Hirotsu Y, Miyashita Y, Goto T, Amemiya K, Mochizuki H, Samamoto I, Ohki T, Oyama T, Honma K, Imamura F, Nishino K, Kumagai T, Omata M. Multiregional sequence revealed SMARCA4 R1192C mutant clones acquired EGFR C797S mutation in the metastatic site of an EGFR-mutated NSCLC patient. Lung Cancer 2020;148:28-32. [PMID: 32777674 DOI: 10.1016/j.lungcan.2020.07.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Sun M, Zhang J. Rampant False Detection of Adaptive Phenotypic Optimization by ParTI-Based Pareto Front Inference. Mol Biol Evol 2021;38:1653-64. [PMID: 33346805 DOI: 10.1093/molbev/msaa330] [Reference Citation Analysis]
40 Azimzade Y, Saberi AA, Gatenby RA. Superlinear growth reveals the Allee effect in tumors. Phys Rev E 2021;103:042405. [PMID: 34005934 DOI: 10.1103/PhysRevE.103.042405] [Reference Citation Analysis]
41 Li G, Yang Z, Wu D, Liu S, Li X, Li T, Li Y, Liang L, Zou W, Wu CI, Wang HY, Lu X. Evolution under spatially heterogeneous selection in solid tumors. Mol Biol Evol 2021:msab335. [PMID: 34850073 DOI: 10.1093/molbev/msab335] [Reference Citation Analysis]
42 Zheng X, Yu C, Xu M. Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy. Front Oncol 2021;11:678333. [PMID: 34262865 DOI: 10.3389/fonc.2021.678333] [Reference Citation Analysis]
43 Ray A, Kunhiraman H, Perera RJ. The Paradoxical Behavior of microRNA-211 in Melanomas and Other Human Cancers. Front Oncol 2020;10:628367. [PMID: 33628737 DOI: 10.3389/fonc.2020.628367] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]